Discovery and characterization of AZ6197, a potent and selective ERK1/2 inhibitor

被引：0
|
作者：
Flemington, Vikki [1 ]
Simpson, Iain [1 ]
Davies, Emma [1 ]
Robinson, David [1 ]
Lindsay, Nicola [1 ]
Hanson, Lyndsey [1 ]
Hopcroft, Philip [1 ]
Tonge, Michael [1 ]
Roberts, Karen [1 ]
Ward, Richard [1 ]
机构：
[1] AstraZeneca, Cambridge, England
来源：
MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期
关键词：
D O I：
10.1158/1535-7163.TARG-17-B156
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B156
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Discovery of Ecallantide: A potent and selective inhibitor of plasma kallikrein
    Ladner, R.
    Kent, R.
    Ley, A.
    Nixon, A.
    Sexton, D.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S312 - S312
  • [42] Discovery of a potent and selective fragment-like inhibitor of SPIN1
    Yan, Xiong
    Greschik, Holger
    Johansson, Catrine
    Seifert, Ludwig
    Bacher, Johannes
    Park, Kwang-su
    Babault, Nicolas
    Martini, Michael
    Fagan, Vincent
    Li, Fengling
    Chau, Irene
    Christott, Thomas
    Dilworth, David
    Barsyte-Lovejoy, Dalia
    Vedadi, Masoud
    Arrowsmith, Cheryl
    Brennan, Paul
    Fedorov, Oleg
    Jung, Manfred
    Farnie, Gillian
    Liu, Jing
    Oppermann, Udo
    Schuele, Roland
    Jin, Jian
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [43] Discovery of a potent and selective Axl inhibitor in preclinical model
    Inoue, Satoshi
    Yamane, Yoshinobu
    Tsukamoto, Shuntaro
    Azuma, Hiroshi
    Nagao, Satoshi
    Murai, Norio
    Nishibata, Kyoko
    Fukushima, Sayo
    Ichikawa, Kenji
    Nakagawa, Takayuki
    Sugi, Naoko Hata
    Ito, Daisuke
    Kato, Yu
    Goto, Aya
    Kakiuchi, Dai
    Ueno, Takashi
    Matsui, Junji
    Matsushima, Tomohiro
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 39
  • [44] Discovery of 1,8-naphthyridin-2-one derivative as a potent and selective sphingomyelin synthase 2 inhibitor
    Yukawa, Takafumi
    Nakahata, Takashi
    Okamoto, Rei
    Ishichi, Yuji
    Miyamoto, Yasufumi
    Nishimura, Satoshi
    Oikawa, Tatsuo
    Kubo, Kazuki
    Adachi, Ryutaro
    Satomi, Yoshinori
    Nakakariya, Masanori
    Amano, Nobuyuki
    Kamaura, Masahiro
    Matsunaga, Nobuyuki
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (07)
  • [45] Discovery of potent, orally bioavailable ERK1/2 inhibitors with isoindolin-1-one structure by structure-based drug design
    Ji, Dezhong
    Zhang, Lingzhi
    Zhu, Qihua
    Bai, Ying
    Wu, Yaoyao
    Xu, Yungen
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 164 : 334 - 341
  • [46] Discovery and characterization of potent, selective CBP degraders
    La Bonte, Laura
    Sappal, Darshan
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [47] Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMR
    Petros, Andrew M.
    Huth, Jeffrey R.
    Oost, Thorsten
    Park, Cheol-Min
    Ding, Hong
    Wang, Xilu
    Zhang, Haichao
    Nimmer, Paul
    Mendoza, Renaldo
    Sun, Chaohong
    Mack, Jamey
    Walter, Karl
    Dorwin, Sarah
    Gramling, Emily
    Ladror, Uri
    Rosenberg, Saul H.
    Elmore, Steven W.
    Fesik, Stephen W.
    Hajduk, Philip J.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6587 - 6591
  • [48] Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279
    Leit, Silvana
    Greenwood, Jeremy
    Carriero, Samantha
    Mondal, Sayan
    Abel, Robert
    Ashwell, Mark
    Blanchette, Heather
    Boyles, Nicholas A. A.
    Cartwright, Mark
    Collis, Alan
    Feng, Shulu
    Ghanakota, Phani
    Harriman, Geraldine C. C.
    Hosagrahara, Vinayak
    Kaila, Neelu
    Kapeller, Rosanna
    Rafi, Salma B. B.
    Romero, Donna L. L.
    Tarantino, Paul M. M.
    Timaniya, Jignesh
    Toms, Angela V. V.
    Wester, Ronald T. T.
    Westlin, William
    Srivastava, Bhaskar
    Miao, Wenyan
    Tummino, Peter
    McElwee, Joshua J. J.
    Edmondson, Scott D. D.
    Masse, Craig E. E.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (15) : 10473 - 10496
  • [49] Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor
    Shimizu, Kazuo
    Fujikura, Hideki
    Fushimi, Nobuhiko
    Nishimura, Toshihiro
    Tatani, Kazuya
    Katsuno, Kenji
    Fujimori, Yoshikazu
    Watanabe, Shinjiro
    Hiratochi, Masahiro
    Nakabayashi, Takeshi
    Kamada, Noboru
    Arakawa, Koichi
    Hikawa, Hidemasa
    Azumaya, Isao
    Isaji, Masayuki
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 34
  • [50] Identification and characterization of a potent and selective inhibitor of human urate transporter 1
    Ting Wu
    Jiasheng Chen
    Shuai Dong
    Haixin Li
    Ying Cao
    Yuanxin Tian
    Weimin Fu
    Pingzheng Zhou
    Baomin Xi
    Jianxin Pang
    [J]. Pharmacological Reports, 2017, 69 : 1103 - 1112
12345